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We are grateful to Phillips et al1 for their interest in our study
evaluating surgeons’ proﬁciency gain curves in relation to survival
after esophageal cancer surgery in Sweden.2 This nationwide clinical
cohort that we have constantly updated and further developed over
the years has some important methodologic advantages that should
not be ignored. The population-based designwith complete and long-
term follow-up of all patients who underwent surgery for esophageal
cancer in Sweden counteracts selection bias, which is otherwise amain
concern in studies evaluating surgical skills, particularly in singe-
center studies. The fact that we have thoroughly collected all
important prognostic factors including tumor stage and comorbidity
on all patients is another important advantage of the cohort. We
believe that the scientiﬁc validity of the study is the key for
making it possible to draw conclusions that can potentially
inﬂuence clinical practice.
We cannot examine the overall experience of the individual
surgeons evaluated in this cohort, but generally, the surgeons
performing esophagectomies in Sweden have a long experience of
surgery for various conditions and subspecialization in upper GI
surgery before they move on to performing esophagectomies. These
operations are usually conducted by the most experienced upper
GI consultant surgeons available at the performing hospital. These
surgeons have gained experience overmany years for how tomanage
various complications after GI surgery, including those relating
to esophagectomy, before they start performing esophagectomies.
The high quality of the surgery is well documented by the low
population-based (unselected) postoperative mortality rates in
Sweden; data from earlier versions of the present cohort show that
the 30-day mortality was only 4.9% in 1997 to 2000 and 2.0% in
2001 to 2005.3,4 Also, the long-term population-based survival
after surgery competes well internationally, with a 5-year survival of
31% since 1997.3,4
The annual surgery volume for esophageal cancer is deﬁnitely
an important prognostic factor.5 This is one of the main reasons
for conducting the current study. However, some data indicate
that annual surgeon volume is more relevant than annual hospital
volume alone. We used data from an earlier version of the present
cohort to evaluate this issue and found that surgeon volume
remained a strong prognostic factor after adjusting for hospital
volume, whereas hospital volume did not remain a prognostic
factor after adjusting for surgeon volume.6
Any effect of training on the learning curve of lymphade-
nectomy is outside the scope of the article and cannot be examined
by the data. Nevertheless, the lymph node yield shown in our article2
is a surrogate to the extent of lymphadenectomy.
We agree that centralization of esophagectomy has contrib-
uted to improving the results after esophageal cancer surgery. In
Sweden, the incidence of esophageal cancer is low, which stresses
the need for centralization even more. The number of cases per
surgeon is clearly lower than in countries with higher incidence
(eg, United Kingdom). Yet, the survival rates after esophagectomy
in Sweden are good, indicating that the quality of this surgery is
still maintained.3,4 Nevertheless, we do agree that further cen-
tralization will provide an environment for surgical mentorship
and probably improve the prognosis in patients with esophageal
cancer in the future. We did not claim that surgeons could reach
competency with a small number of procedures. In contrast,
performing a large number of procedures does not by itself
guarantee competency.
Speciﬁcally, 23.0% and 8.6% of surgeons reached the change
points for 30-day and 3-year mortality at 15 and 35 esophagectomies,
respectively. The risk-adjusted cumulative sum results are the
average results for surgeons performing esophagectomy within
the data set. Obviously, the proﬁciency-gain curves are expected
to be individual between different surgeons. Having said that, it
is nevertheless important to provide ﬁgures based on a large
number of individual surgeons that can help guide clinical
practice. Moreover, excellence in surgery is not just a technical
skill; the main challenges are often how to deal with patient
selection and postoperative complications.
We believe, in agreement with Phillips et al,1 that surgeons
who aim to conduct esophagectomy for cancer should be included
in structured training programs and be trained in high-volume
centers that have a wide range of experience in such surgery. This
could substantially improve the prognosis in patients diagnosed
with esophageal cancer.
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